ClinicalTrials.Veeva

Menu

Effect of Topical Dexmedetomidine on Intraocular Pressure

B

Beirut Eye Specialist Hospital

Status and phase

Completed
Phase 4

Conditions

Glaucoma
Intraocular Pressure

Treatments

Drug: Balanced salt solution
Drug: Dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

NCT03690622
BeirutEyeSH

Details and patient eligibility

About

Evaluate the short-term safety and efficacy of dexmedetomidine (0.0055%) drops on intraocular pressure (IOP) in healthy eyes.

Enrollment

49 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with healthy eyes and no history of glaucoma

Exclusion criteria

  • history of glaucoma, IOP > 24mmHg at baseline, abnormal optic nerve on fundus examination, keratoconus, corneal graft, corneal edema or a history of refractive surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

49 participants in 2 patient groups

BSS
Sham Comparator group
Description:
Balanced salt solution
Treatment:
Drug: Balanced salt solution
Dexmedetomidine
Active Comparator group
Description:
dexmedetomidine (0.0055%)
Treatment:
Drug: Dexmedetomidine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems